About Sai Parenterals Ltd
Sai Parenteral's is a diversified pharmaceutical formulations company with capabilities in research, development and manufacturing. We are in the business of (i) Branded Generic Formulations and (ii) Contract Development and Manufacturing Organisation (“CDMO”) products and services for the domestic and international markets.
Founded
2001
CEO
ANIL KUMAR KARUSALA
Employees
289
HQ
Ranga Reddy, Telangana
Finished Products
1Sale of Products
₹237.74Cr2Other Operating Revenues
₹0.27Cr3Sale of Services
₹0.15CrRaw Materials
1Cost of Materials Consumed
₹145.48CrAbout Sai Parenterals Ltd
Sai Parenteral's is a diversified pharmaceutical formulations company with capabilities in research, development and manufacturing. We are in the business of (i) Branded Generic Formulations and (ii) Contract Development and Manufacturing Organisation (“CDMO”) products and services for the domestic and international markets.
Founded:2001
CEO:ANIL KUMAR KARUSALA
Employees:289
HQ:Ranga Reddy, Telangana
Finished Products
1Sale of Products
₹237.74Cr2Other Operating Revenues
₹0.27Cr3Sale of Services
₹0.15CrRaw Materials
1Cost of Materials Consumed
₹145.48CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹706
52W Low
₹400
Volume44.10K
Avg VolumeN/A
BetaN/A
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
110.39x
Valuation
P/B Ratio
4.67x
Valuation
EPS
₹4.70
Valuation
Dividend Yield
0.00%
Valuation
ROE
2.91%
Profitability
ROCE
2.79%
Profitability
Revenue by Segment
Contribution & growth by business line
No segment revenue data available
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.68x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
35.3%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.